Biologic, thiopurine IBD treatment during pregnancy does not affect maternal, child outcomes
Among pregnant women with inflammatory bowel diseases (IBDs), treatment with thiopurine, biologics, or a combination of both does not seem to worsen maternal or foetal outcomes, a new study has shown.
Biologic, thiopurine IBD treatment during pregnancy does not affect maternal, child outcomes
22 Mar 2021